AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme

Clinical trial NCT00107237 · COMPLETED

Trial details

NCT number: NCT00107237
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2003-10-01
Primary completion: 2006-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.